Cue Biopharma (CUE) Other Working Capital Changes (2017 - 2025)

Cue Biopharma has reported Other Working Capital Changes for 9 years, with the latest figure at -$518000.0 in Q4 2025.

• Quarterly Other Working Capital Changes fell 260.87% year-over-year to -$518000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.6 million (down 29.44% YoY) and the FY2025 annual result came in at -$2.6 million, down 29.44% from the prior year.
• Other Working Capital Changes grew to -$518000.0 in Q4 2025 per CUE's latest filing, from -$3.6 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.6 million in Q1 2021 and troughed at -$3.6 million in Q3 2025.
• A 5-year average of -$401578.3 and a median of -$435000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2021 and 2023: Other Working Capital Changes slumped 1219.85% in 2021, then surged 1497.89% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$816566.0 in 2021, then plunged by 93.62% to -$1.6 million in 2022, then plunged by 96.84% to -$3.1 million in 2023, then soared by 110.35% to $322000.0 in 2024, then slumped by 260.87% to -$518000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$518000.0, -$3.6 million, and $467000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.